Acer Therapeutics Inc (ACER) is lower by Friday morning, with the stock falling -10.16% in pre-market trading to 1.15. ACER's short-term technical score of 87 indicates that the stock has traded more bullishly over the last month than 87% of stocks on the market. In the Biotechnology industry, which ranks 133 out of 146 industries, ACER ranks higher than 96% of stocks. Acer Therapeutics Inc has risen 50.59% over the past month, closing at $0.76 on August 4. During this period of time, the stock fell as low as $0.57 and as high as $1.01. ACER has an average analyst recommendation of Strong Buy. The company has an average price target of $9.67.
ACER has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on ACER!